Venrock Healthcare Capital Partners III, L.P.: insider trades and track record
As of Nov 4, 2026, Venrock Healthcare Capital Partners III, L.P. filed 22 open-market purchases worth $43.8M in 2 companies since Jan 8, 2024, from Form 4 filings. At the latest insider trade price in each stock, 10 of 11 purchases are worth more than the price paid (median change +3%).
Latest filing Nov 4, 2026. From Form 4 filings. Data only, not investment advice.
At a glance
Track record by company
One row per company: what they paid, what they got for shares sold later, and how the shares they still hold compare with the latest insider trade price.
| Stock | Role | Bought | Avg price paid | Result on shares sold | Shares still held | Latest price | Change on held shares |
|---|---|---|---|---|---|---|---|
| LYCA | 10% owner | $38.5M | $18.53 | – | 2.08M | $26.95 Nov 2, 2026 | +46% |
| KALV | 10% owner | $5.3M | $12.46 | – | 422,092 | no recent trade | – |
Every purchase and the latest price
Each open-market purchase, next to the most recent price any insider paid or received for the same stock.
| Date | Stock | Shares | Price paid | Value | Latest price | Change |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | LYCA | 8,305 | $26.95 | $224K | no later trade | – |
| Oct 30, 2026 | LYCA | 8,804 | $26.27 | $231K | $26.95 Nov 2, 2026 | +3% |
| Oct 30, 2026 | LYCA | 200 | $26.86 | $5.4K | $26.95 Nov 2, 2026 | 0% |
| Oct 29, 2026 | LYCA | 1,000 | $26.33 | $26.3K | $26.95 Nov 2, 2026 | +2% |
| Oct 28, 2026 | LYCA | 10,570 | $25.23 | $267K | $26.95 Nov 2, 2026 | +7% |
| Oct 28, 2026 | LYCA | 4,430 | $25.97 | $115K | $26.95 Nov 2, 2026 | +4% |
| Oct 27, 2026 | LYCA | 8,729 | $25.84 | $226K | $26.95 Nov 2, 2026 | +4% |
| Oct 27, 2026 | LYCA | 31,067 | $26.84 | $834K | $26.95 Nov 2, 2026 | 0% |
| Oct 26, 2026 | LYCA | 1.94M | $18.00 | $35M | $26.95 Nov 2, 2026 | +50% |
| Oct 26, 2026 | LYCA | 8,261 | $26.97 | $223K | $26.95 Nov 2, 2026 | 0% |
| Oct 23, 2026 | LYCA | 24,560 | $25.68 | $631K | $26.95 Nov 2, 2026 | +5% |
| Oct 23, 2026 | LYCA | 28,379 | $26.11 | $741K | $26.95 Nov 2, 2026 | +3% |
| Feb 11, 2025 | KALV | 26,703 | $9.18 | $245K | no later trade | – |
| Feb 10, 2025 | KALV | 4,137 | $9.14 | $37.8K | no later trade | – |
| Feb 7, 2025 | KALV | 73,649 | $9.29 | $684K | no later trade | – |
| Jan 30, 2024 | KALV | 88,099 | $14.47 | $1.3M | no later trade | – |
| Jan 29, 2024 | KALV | 80,600 | $14.22 | $1.1M | no later trade | – |
| Jan 26, 2024 | KALV | 4,174 | $12.98 | $54.2K | no later trade | – |
| Jan 25, 2024 | KALV | 7,030 | $12.73 | $89.5K | no later trade | – |
| Jan 10, 2024 | KALV | 47,700 | $12.67 | $604K | no later trade | – |
| Jan 9, 2024 | KALV | 20,816 | $12.56 | $261K | no later trade | – |
| Jan 8, 2024 | KALV | 69,184 | $12.44 | $861K | no later trade | – |
How this track record is worked out
- Only open-market purchases and sales (Form 4 codes P and S) from the last 3 years. Shares received as pay, from options or before that window are not purchases, so they never count toward a return.
- Result on shares sold matches each sale with this insider's own earlier purchases in the same company, oldest first, using the prices in their filings.
- Latest price is the price of the most recent open-market trade any insider filed in that company, with its date. It is not a live stock quote, and it is not shown when it is more than 120 days old.
- Prices are adjusted for stock splits, found when the company's shares outstanding (from its 10-Q and 10-K covers) and the trade prices move by the same split ratio.
- A trade reported jointly by several owners (a fund, its manager, its partners) is shown once, under the first owner named in the filing.
- Past results say nothing about future trades. This is a record of filings, not a recommendation.
All open-market trades
Purchases and sales by month for the last 3 years. Click a month to see only its trades.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.